Point72 Asset Management, L.P.
Position in XENE — Xenon Pharmaceuticals Inc.
CIK 1603466
STAMFORD, CT
Position in XENE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,869,616
+$7,869,616 QoQ
Shares Held
130,378
Ownership
0.135%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#98
of 314 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Derivatives in XENE
reported options exposure · as of Mar 31, 2026CallValue
$540,795
CallShares
9,300
PutValue
$540,795
PutShares
9,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. XENE ranks #64 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,869,616 | 130,378 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $540,795 | 9,300 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $540,795 | 9,300 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $416,826 | 9,300 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $416,826 | 9,300 | Call | Defined | 2026-02-17 | |
| 2025-03-31 | $7,037,414 | 209,759 | Shares | Defined | 2025-07-21 | |
| 2024-09-30 | $15,090,127 | 383,290 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,794,037 | 482,022 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $11,875,729 | 275,859 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $40,305,493 | 875,065 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $38,454,185 | 1,125,708 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,706,008 | 148,208 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,060,492 | 504,624 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $46,461,315 | 1,178,324 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $59,206,599 | 1,640,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,423,812 | 901,506 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $65,616,976 | 2,146,450 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $93,488,730 | 2,992,597 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $16,468,784 | 1,077,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,800,826 | 902,300 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $13,621,917 | 761,001 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,274,417 | 472,979 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,948,965 | 447,061 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,268,926 | 659,404 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,634,501 | 585,053 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||